Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven for perioperative protein vascular leakage in severe orthopedic trauma
ChiCTR1800015469Phase 4Recruiting
- Sponsor
- Yantai Mountain Hospital
- Start
- Mar 2018
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Volulyte in capillary leak syndrome (SCLS) and hypoproteinemia (2 arms), sponsored by Yantai Mountain Hospital. Primary endpoints: Blood biochemical indices, Immunological indices and 1 more. Started Mar 2018; status: recruiting.
02
Drugs
Volulyte
03
Conditions
capillary leak syndrome (SCLS)hypoproteinemia
Beyond the preview
Go deeper on ChiCTR1800015469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015469.